Page last updated: 2024-10-30

leflunomide and Infection, Mycobacterium avium-intracellulare

leflunomide has been researched along with Infection, Mycobacterium avium-intracellulare in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winetsky, DE1
Myers, J1
Schulz, S1
Tino, G1
Wilck, M1

Other Studies

1 other study available for leflunomide and Infection, Mycobacterium avium-intracellulare

ArticleYear
A Case of Cavitary Pulmonary Mycobacterium Avium Intracellulare Infection in the Setting of Leflunomide Treatment.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2017, Volume: 23, Issue:4

    Topics: Aged; Antitubercular Agents; Arthritis, Rheumatoid; Drug Monitoring; Drug Substitution; Female; Huma

2017